BRENDA MESSER: Open Payments
NPI 1356820179 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 19 payments from 14 companies in 2025. Trend: 2023 $1,436 · 2024 $200 · 2025 $467
Food & beverage: $381Education: $86
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 2 | $110 |
| ABBVIE INC. | 2 | $49 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Incyte Corporation | 2 | $35 |
| SOBI, INC | 1 | $27 |
| Astellas Pharma US Inc | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Dendreon Pharmaceuticals LLC | 1 | $20 |
| Caris MPI, Inc. | 1 | $19 |
Products named: FOTIVDA, ELAHERE, KISQALI, Enhertu, Doptelet, Vyloy, LIBTAYO, PROVENGE.
Industry payments across MO — which companies pay providers there.
